Business WSJ News Exclusive | Amgen in Advanced Talks to Buy Horizon Therapeutics [ad_1] WSJ News Exclusive Business U.S. biotechnology company was the last of three suitors standing in an auction for Horizon [ad_2] Source link Related Topics:acquisitionsAcquisitions/MergersAcquisitions/Mergers/ShareholdingsAmgenAMGNBiologyBiopharmaceuticalsBiotechnologyC&E Industry News FilterContent TypescorporateCorporate ActionsCorporate/Industrial NewsFactiva FiltersGeneral newsHealthcareHealthcare/Life SciencesHorizon TherapeuticshumanitiesHZNPindustrial newskwexclusivelife sciencesMerck &mergersMRKOwnership changesPFEPfizerPharmaceuticalspoliticalPolitical/General NewsRetailRetail/WholesalesciencesSciences/HumanitiesshareholdingssyndwholesaleWholesalersWSJ-PRO-WSJ.comwsjfinance-ws